October 29, 2026

FDA, CMS target gene therapy barriers

FDA and CMS initiatives aim to simplify gene therapy approvals and expand access to treatments for rare diseases.

MDSpire News

October 29, 2026

FDA proposes major infant formula update after nearly 30 years

Proposed changes target 4 key nutrients, requesting public input on whether additional ingredients should become mandatory.

MDSpire News

October 29, 2026

CDC mandates Ebola attestation for US-bound flights

The new requirement applies to US citizens, permanent residents, and foreign travelers.

MDSpire News

October 28, 2026

FDA adds generic valganciclovir oral solution

 The new option is indicated for CMV prophylaxis in pediatric kidney and heart transplant recipients, as well as adult CMV retinitis and transplant prophylaxis.

MDSpire News

October 27, 2026

Endometrial cancer drug cuts progression or death risk 41%

FDA grants Priority Review following improved survival versus chemotherapy in phase 3 trial.

MDSpire News

October 27, 2026

FDA expands talazoparib use in prostate cancer

The combination with enzalutamide reduced the risk of radiographic progression or death by 52% .

MDSpire News

October 27, 2026

CDC chief medical officer resigns after 6 months

Jennifer Shuford, MD, MPH, will leave the agency November 12, with an acting successor named.

MDSpire News

October 26, 2026

FDA expands weekly insulin use to children

Insulin icodec-abae offers a weekly basal insulin option for pediatric type 2 diabetes, supported by adult trials and pediatric pharmacokinetic data.

MDSpire News

October 23, 2026

FDA clears at-home risankizumab induction

Week 12 remission reached 56% vs. 30% with placebo, with the FDA revising tuberculosis testing precautions.

MDSpire News

October 22, 2026

FDA clears integrated kidney replacement system

The system combines citrate anticoagulation and calcium replacement for critically ill patients receiving continuous kidney replacement therapy.

MDSpire News